Global Retirement Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Global Retirement Partners’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.48K	Buy	192 +59	+44%	+$1.31K	﹤0.01%	3472
2025 Q3	$2.62K	Sell	133 -890	-87%	-$18.3K	﹤0.01%	3222
2025 Q2	$22.2K	Buy	+1,023	New	+$24.1K	﹤0.01%	2237
2024 Q4	$3.78K	Buy	181 +8	+5%	+$172	﹤0.01%	2820
2024 Q3	$3.44K	Sell	173 -548	-76%	-$10.2K	﹤0.01%	2729
2024 Q2	$11.2K	Buy	721 +651	+930%	+$10.1K	﹤0.01%	2272
2024 Q1	$1.12K	Sell	70 -104	-60%	-$1.57K	﹤0.01%	2949
2023 Q4	$2.5K	Buy	174 +101	+138%	+$1.38K	﹤0.01%	2590
2023 Q3	$883	Buy	73 +21	+40%	+$281	﹤0.01%	2804
2023 Q2	$699	Sell	52 -1	-2%	-$14	﹤0.01%	2868
2023 Q1	$880	Buy	+53	New	+$874	﹤0.01%	2773

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Global Retirement Partners's CPRX Position: Q4 2025 in Review

Global Retirement Partners increased its Catalyst Pharmaceutical (CPRX) stake by 44% in Q4 2025, buying an estimated $1.31K and bringing the position to 192 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3472.

Global Retirement Partners first reported a position in CPRX in Q1 2023 and has held it in 11 quarters since. The position peaked at $22.2K in Q2 2025. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

Global Retirement Partners held 192 shares of Catalyst Pharmaceutical worth $4.48K as of Q4 2025.
Global Retirement Partners bought 59 Catalyst Pharmaceutical shares in Q4 2025, an estimated $1.31K.
Catalyst Pharmaceutical made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3472 holding.
Global Retirement Partners first reported a position in Catalyst Pharmaceutical in Q1 2023 and has held it in 11 quarters since.
Global Retirement Partners's Catalyst Pharmaceutical position peaked at $22.2K in Q2 2025.
373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.